Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome
The main purpose of this study is to determine which is the best dose of a drug known as Dysport to give when treating one’s type of upper back pain. The study will also examine the side effects of this treatment and its overall effect on one’s disorder.
Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome
- 29 August 2024 - 1 mins read
The main purpose of this study is to determine which is the best dose of a drug known as Dysport to give when treating one’s type of upper back pain. The study will also examine the side effects of this treatment and its overall effect on one’s disorder.
Related Clinical Trials
29 August 2024
1 mins read
A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072
29 August 2024
1 mins read
Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic...
29 August 2024
1 mins read
Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs
29 August 2024
1 mins read
Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer
29 August 2024
1 mins read
To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
29 August 2024
1 mins read
Study to Compare a Dose of Telotristat Etiprate in Subjects With Renal Impairment With Matched Subjects With Normal Renal Function
29 August 2024
1 mins read
Study to Evaluate a Dose of Telotristat Etiprate in Male and Female With Mild, Moderate and Severe Hepatic Insufficiency and Matched Healthy Subjects
29 August 2024
1 mins read
Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETs
29 August 2024
1 mins read
A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty.
29 August 2024
1 mins read